🌱 We're a young nonprofit building now — and we need founding donors and volunteers to launch our research and education.
IRS-recognized 501(c)(3) public charityFree full-length science book72 peer-reviewed sourcesDonor-supported — no industry funding
Our Approach
Where others ask "how do we treat what's broken?" we ask "how do we unlock what's possible?"
Today's psychedelic renaissance focuses almost entirely on treating illness. Metanoia prioritizes the everyday, healthy person — someone not seeking therapy, but aspiring to elevate their well-being, creativity, self-awareness, and potential — through a multidisciplinary research approach integrating neuroscience, genetics, chemistry, and therapeutic practice.
Multidisciplinary Research
Five integrated disciplines driving a 360° understanding
Neuroscience
How psychedelics — psilocybin, LSD, ayahuasca, iboga — affect brain activity, neuroplasticity, and cognition, in plain language.
Read more
Our Approach
Neuroscience
Everything a psychedelic does begins with one molecular handshake: psilocin binding to the serotonin 2A receptor. What that does at the scale of the whole mind — loosening the brain's habitual filters, briefly making thought more fluid — is where the science gets interesting.
The discovery that matters most for us is neuroplasticity, and it runs across the whole family: psilocybin, ayahuasca, and iboga each appear to switch on the brain's machinery of structural change, opening a temporary window when the brain is unusually ready to form new patterns. For healthy people seeking growth, that window may be the whole point.
Whether genetic factors shape how individuals respond to psychedelics — across the whole family — for personal development.
Read more
Our Approach
Genetics
Why do two people take the same dose and have completely different experiences? Part of the answer is genetic — the enzymes that break psilocin down, and the natural variants of the receptor it acts on, differ from person to person. In some trials, a real fraction of volunteers showed no clear response at all.
No human study has yet linked a specific genotype to the strength of a psychedelic experience — with psilocybin, LSD, or anything else in the family. Closing that gap is a step toward safer, more personalized frameworks for growth — matching approach to individual rather than treating everyone the same.
Studying natural sources — mushrooms, cacti, vines, and bark — as whole chemical systems, not single molecules.
Read more
Our Approach
Chemistry
Since 1958, science has largely treated the psilocybin mushroom as a delivery device for one molecule. We study it as what it actually is: a living chemical system — psilocybin alongside its relatives and an "entourage" of related compounds, all built along one short enzymatic pathway.
Whether that whole system does something a single purified molecule does not — the entourage question — is one of the field's most consequential open problems. We map the evidence honestly, from the biochemistry to the ethnobotanical roots, marking exactly where the solid ground ends.
How growing conditions, genetics, and species shape a mushroom's real chemistry — the source of the fortyfold potency gap.
Read more
Our Approach
Cultivation
Potency is not a fixed property of a species — it is an outcome of how the organism was grown. Analyses find variation of up to fortyfold between mushroom samples, which makes cultivation a scientific variable, not a hobbyist footnote.
Substrate, species and strain, environmental conditions, and the moment of harvest all shape the final chemical profile — not only psilocybin, but the whole entourage of related compounds. Understanding that pathway is a prerequisite for any research that expects to be reproducible.
Evidence-based frameworks for safe preparation, experience, and integration — across every substance in the family.
Read more
Our Approach
Therapy
The molecule is only half the story. Set and setting — the state of mind and the surroundings — are primary determinants of whether an experience helps or harms. Every tradition knew this: the mushroom velada, the ayahuasca ceremony, the iboga initiation — each was always taken in context, with guidance.
We develop evidence-based frameworks for the whole arc — preparation, the experience itself, and the integration afterward that turns insight into lasting change. If a plasticity window is real, integration is where its value is captured or lost. Metanoia conducts research and education; we do not supply any controlled substance.
Expanding human consciousness — studied rigorously, shared openly.
Why It Matters
A large, unmet, and largely overlooked need
+70%
rise in depression & anxiety among young adults
2%+
of the world lives with treatment-resistant depression
Most
research still targets illness, not growth in healthy people
Few
qualified, science-based frameworks for growth-focused use
We translate peer-reviewed research — from journals like Nature, Science, and JAMA Psychiatry — into knowledge people can actually use.
PressThe Mushroom as a Chemical SystemBeyond a single molecule · 2026 edition
Public Education
We publish what we learn — free to everyone
Research only matters if people can use it. Alongside our guides and education pages, our first full-length open-access title explores psilocybin mushrooms not as one molecule but as a living chemical system — biosynthesis, the entourage of related compounds, dose and variability, cultivation, and the ethics of traditional knowledge. Rigorous for experts, clear for newcomers, and free for both.
Today Metanoia is a California 501(c)(3) public charity, and nothing else — it leads research direction, public education, governance, and fundraising. Our long-term plan adds a separate for-profit research affiliate to carry applied R&D and raise investment capital, work a charity is poorly suited to fund. That affiliate has not been formed.
All public education and fundraising benefits the nonprofit mission.
"The psychedelic renaissance is happening with or without proper guidance. Our choice is whether it unfolds safely, scientifically, and equitably — and whether it serves the everyday person seeking to thrive, not only the patient seeking a cure."
Metanoia is built around the science, not around personalities. You won't find our faces here — and that's on purpose.
Join our community — get the free Integration Guide
Subscribe and instantly receive our 7-page Integration Guide (PDF) — the evidence on turning a psychedelic experience into lasting change. Plus research updates and education news. No noise.
